Corient Private Wealth’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Sell
205,045
-314,479
-61% -$2.15M ﹤0.01% 1404
2025
Q4
$738K Buy
519,524
+323,233
+165% +$732K ﹤0.01% 2067
2025
Q3
$483K Sell
196,291
-9,304
-5% -$24K ﹤0.01% 1809
2025
Q2
$543K Sell
205,595
-22,073
-10% -$59.4K ﹤0.01% 1664
2025
Q1
$685K Buy
227,668
+5,288
+2% +$16K ﹤0.01% 1450
2024
Q4
$569K Sell
222,380
-224,080
-50% -$933K ﹤0.01% 1548
2024
Q3
$1.66M Buy
446,460
+224,380
+101% +$1.04M ﹤0.01% 1180
2024
Q2
$1.4M Buy
222,080
+550
+0.2% +$3.63K ﹤0.01% 1189
2024
Q1
$1.19M Sell
221,530
-1,900
-0.9% -$8.6K ﹤0.01% 1252
2023
Q4
$1.12M Buy
223,430
+49,729
+29% +$156K ﹤0.01% 1238
2023
Q3
$294K Buy
173,701
+114,272
+192% +$229K ﹤0.01% 1755
2023
Q2
$165K Sell
59,429
-53
-0.1% -$150 ﹤0.01% 1909
2023
Q1
$108K Buy
59,482
+35,852
+152% +$111K ﹤0.01% 1873
2022
Q4
$120K Buy
+23,630
New +$130K ﹤0.01% 1547

Other funds holding IBRX